Evidence map›Paper›PMID 26290569›Full record

ArticleG3 (Bethesda, Md.)2015

Genomic-Enabled Prediction of Ordinal Data with Bayesian Logistic Ordinal Regression.

Osval A Montesinos-López, Abelardo Montesinos-López, José Crossa, Juan Burgueño, Kent Eskridge

Abstract read
In one paragraph

Article in G3 (Bethesda, Md.), 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 12 papers.

0numbers the graph read from it
0cells of the map it votes in
12citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

12 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Review
  6. Article
  7. Review
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Osval A Montesinos-LópezFacultad de Telemática, Universidad de Colima, C.P. 28040 Colima, Colima, México.
Abelardo Montesinos-LópezDepartamento de Estadística, Centro de Investigación en Matemáticas (CIMAT), 36240 Guanajuato, México.
José CrossaBiometrics and Statistics Unit, International Maize and Wheat Improvement Center (CIMMYT), 06600 México, Distrito Federal, México j.crossa@cgiar.org.ORCID http://orcid.org/0000-0001-9429-5855
Juan BurgueñoBiometrics and Statistics Unit, International Maize and Wheat Improvement Center (CIMMYT), 06600 México, Distrito Federal, México.
Kent EskridgeUniversity of Nebraska, Statistics Department, Lincoln, Nebraska 68583-0963.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Most genomic-enabled prediction models developed so far assume that the response variable is continuous and normally distributed. The exception is the probit model, developed for ordered categorical phenotypes. In statistical applications, because of the easy implementation of the Bayesian probit ordinal regression (BPOR) model, Bayesian logistic ordinal regression (BLOR) is implemented rarely in the context of genomic-enabled prediction [sample size (n) is much smaller than the number of parameters (p)]. For this reason, in this paper we propose a BLOR model using the Pólya-Gamma data augmentation approach that produces a Gibbs sampler with similar full conditional distributions of the BPOR model and with the advantage that the BPOR model is a particular case of the BLOR model. We evaluated the proposed model by using simulation and two real data sets. Results indicate that our BLOR model is a good alternative for analyzing ordinal data in the context of genomic-enabled prediction with the probit or logit link.

Indexed as

Bayes TheoremLogistic ModelsModels, GeneticAlgorithmsComputer SimulationDatasets as TopicGenomicsPlant DiseasesTriticumZea maysBayesian ordinal regressiongenomic selectionGenPredGibbs samplerlogitprobitshared data resource

Identifiers

PMID26290569
PMCPMC4592994

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.